LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 199 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $120 | -96.7% | 2 | -96.0% | 0.00% | -100.0% |
| Q2 2023 | $3,605 | -2.0% | 50 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $3,678 | +10.1% | 50 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $3,340 | -16.5% | 50 | +2.0% | 0.00% | 0.0% |
| Q3 2022 | $4,000 | 0.0% | 49 | +19.5% | 0.00% | 0.0% |
| Q2 2022 | $4,000 | – | 41 | +1266.7% | 0.00% | – |
| Q1 2022 | $0 | -100.0% | 3 | -93.8% | 0.00% | -100.0% |
| Q3 2021 | $7,000 | +40.0% | 48 | +182.4% | 0.00% | 0.0% |
| Q3 2018 | $5,000 | +25.0% | 17 | 0.0% | 0.00% | +100.0% |
| Q2 2018 | $4,000 | +33.3% | 17 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $3,000 | +50.0% | 17 | +30.8% | 0.00% | 0.0% |
| Q4 2017 | $2,000 | 0.0% | 13 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $2,000 | 0.0% | 13 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $2,000 | +100.0% | 13 | 0.0% | 0.00% | – |
| Q1 2017 | $1,000 | 0.0% | 13 | +30.0% | 0.00% | – |
| Q4 2016 | $1,000 | – | 10 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $8,459 | 3.32% |
| VILLERE ST DENIS J & CO LLC | 480,807 | $35,368,162 | 2.57% |
| Chicago Capital, LLC | 449,508 | $33,065,822 | 1.64% |
| RICE HALL JAMES & ASSOCIATES, LLC | 288,345 | $21,210,681 | 1.20% |
| Smith, Graham & Co., Investment Advisors, LP | 65,163 | $4,793,390 | 0.58% |
| Stephens Investment Management Group LLC | 455,089 | $33,476,347 | 0.56% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 201,993 | $14,858,605 | 0.53% |
| WOODSTOCK CORP | 52,604 | $3,869,550 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,142,607 | 0.41% |
| Jackson Creek Investment Advisors LLC | 12,726 | $936 | 0.39% |